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Abstract
Background: Primary hyperparathyroidism (pHPT) is a common disease that often remains undetected and causes 
severe disturbance especially in postmenopausal women. Therefore, national recommendations promoting early pHPT 
detection by plasma calcium (P-Ca) have been issued in Sweden. In this study we aimed to investigate variation of P-Ca 
analysis between physicians and health care centres (HCCs) in primary care in county of Skaraborg, Sweden.
Methods: In this cross sectional study of patients' records during 2005 we analysed records from 154 629 patients 
attending 457 physicians at 24 HCCs. We used multilevel logistic regression analysis (MLRA) and adjusted for patient, 
physician and HCC characteristics. Differences were expressed as median odds ratio (MOR).
Results: There was a substantial variation in number of P-Ca analyses between both HCCs (MORHCC 1.65 [1.44-2.07]) 
and physicians (MORphysician 1.95 [1.85-2.08]). The odds for a P-Ca analysis were lower for male patients (OR 0.80 [0.77-
0.83]) and increased with the number of diagnoses (OR 25.8 [23.5-28.5]). Sex of the physician had no influence on P-Ca 
test ordering (OR 0.93 [0.78-1.09]). Physicians under education ordered most P-Ca analyses (OR 1.69 [1.35-2.24]) and 
locum least (OR 0.73 [0.57-0.94]). More of the variance was attributed to the physician level than the HCC level. Different 
mix of patients did not explain this variance between physicians. Theoretically, if a patient were able to change both GP 
and HCC, the odds of a P-Ca analysis would in median increase by 2.45. Including characteristics of the patients, 
physicians and HCCs in the MLRA model did not explain the variance.
Conclusions: The physician level was more important than the HCC level for the variation in P-Ca analysis, but further 
exploration of unidentified contextual factors is crucial for future monitoring of practice variation.
Background
Primary hyperparathyroidism (pHPT) is a common dis-
ease that often remains undetected and causes severe dis-
turbance especially in postmenopausal women.
Therefore, national recommendations promoting early
pHPT detection by plasma calcium (P-Ca) have been
issued in Sweden [1,2]. In this study we aimed to investi-
gate variation of P-Ca analysis between physicians and
health care centres (HCCs).
pHPT is a potentially serious condition leading to
increased morbidity and mortality from cardiovascular
disease [3] and cancer [4]. Although mild disease might
not increase the risk [5]. PHPT gives raised plasma cal-
cium (P-Ca) and because of the vague symptoms, pHPT
is difficult to detect without an analysis of P-Ca.
Even though previous studies indicate that the fre-
quency of P-Ca analyses differs between health care cen-
tres (HCC) [6] the understanding of the relative
importance of the different levels (patients, physicians,
HCCs) for these differences is limited. However, in a
study from New Zealand where a defined clinical situa-
tion was presented to GPs, it was shown that inherent
characteristics of the physicians more than the patients
clinical situation determined which laboratory tests were
ordered [7]. A study from the Netherlands, without
patient characteristics, found a regional variation in labo-
ratory testing and that factors at both the physician and
HCC level influenced the inclination to order tests [8].
The aim of this study was to investigate the relative
importance of the different levels in the health care orga-
nization for P-Ca analyses using the Skaraborg Primary
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Care Database (SPCD). Identification of factors contrib-
uting to the variation can be of relevance for planning
interventions for an optimal frequency of P-Ca analyses
and for evaluating the national recommendations.
Methods
Study population
Skaraborg is a rural area in Sweden and comprised 255
758 inhabitants in 2005. The public primary care is a part
of the Västra Götaland region and serves 97% of the pop-
ulation (n = 247 985). All the HCCs (n = 24) use the same
computerised medical record, ProfDoc Journal III (PDIII
ProfDoc AB: Uppsala) facilitating data extraction. SPCD
has been created containing encrypted data from patients
and caregivers from all HCCs. The database contains
patients' age, sex, diagnoses, laboratory analyses, and
drug prescriptions. The HCCs' laboratory facilities are
accredited by SWEDAC (the Swedish Board for Accredi-
tation and Conformity Assessment). The validity of the
information in the database has recently been audited
and judged to be mostly appropriate but varying with
type of diagnosis [9]. All 154 629 individuals that
attended any of the 24 HCCs during 2005 are included in
the analysis. The local ethics committee at Gothenburg
University approved the study (255-09).
Study procedure and assessment of variables
The outcome variable was P-Ca analyses during 2005
(yes/no). Sex of the patient and P-Ca analyses during
2004, were included as explanatory variables. We also
selected ICD-10 coded diagnoses and symptoms associ-
ated with pHPT [10] . A risk score for a P-Ca analysis was
created with stepwise logistic regression [11] based on
age, concomitant diagnosis and drug treatment, in order
to control for confounding factors. The risk score was
divided in quintiles, patients with the lowest risk of P-Ca
analyses (group 1) were used as reference. The main char-
acteristics included in the risk score are listed in Table 1
A more detailed description can be found in additional
file 1.
The physicians were categorised according to sex and
title. GP and locum were also dichotomised at 46 year .
GPs, 46 years or older, were used as reference in the anal-
ysis. As only six doctors among house officers and pre-
registration house officers were above 45 years, they were
not dichotomised.
The HCCs had different standardised group analyses,
for instance analyses of electrolytes, hypertension check
ups and diagnosing dementia, in which P-Ca was
included. We categorised HCCs as having none, 1-2, and
≥ 3 standardised groups including P-Ca. The HCCs hav-
ing no group analyses were used as reference.
Statistical analysis
We used multilevel logistic regression analysis (MLRA) to
estimate the odds of patients being ordered a P-Ca analy-
sis, as the data had a hierarchical structure (i.e., patients
nested within physicians nested within HCCs) [12,13]. As
one patient could attend several physicians and several
HCCs, we used a multiple membership model (Figure 1)
[14] . The weights were constructed according to number
of visits to a certain physician/HCC during our study
period.
We developed four consecutive models. Model A
included the random parameters (physicians and HCCs),
in order to partition the variance at different levels.
Model B included the patient characteristics, model C the
patient and physician characteristics and model D the
patient, physician and HCC characteristics. In this way
we could investigate whether the contextual characteris-
tics explained the residual variation at the physician and
HCC levels.
In the fixed-effects part of the MLRA, we calculated
odds ratios (OR) and their 95% credible intervals (95%
C I ) .  I n  t h e  r a n d o m - e f f e c t s  p a r t  o f  t h e  M L R A ,  w e
obtained the variance at the physician and HCC levels. In
order to quantify the importance of the different levels in
the analysis we calculated the median odds ratio (MOR)
[15,16]. The MOR translates the variance into the widely
used OR scale, and can thereby be directly compared with
the ORs of individual or area variables. In very simple
terms, the MOR could be interpreted as how much a
patient's odds of being ordered a P-Ca analysis would (in
median) increase if this patient moved to a physician/
HCC with higher odds of ordering a P-Ca analysis. A
MOR of one indicates that there are no differences
between physicians/HCCs in their odds of ordering P-Ca
analysis. The larger the differences between physicians/
HCCs are, the larger the MOR will be. The MORphysi-
cian+HCC is applicable to patients that visited only one phy-
sician during the study period. Parameters were
estimated by MCMC methods [17] in the MLwiN 2.02
software [18].
Results
Overall 5.8% of the inhabitants in Skaraborg and 9% of
the patients (11% of the women and 8% of the men)
attending the HCCs had a P-Ca analysis. The mean age of
the patients with P-Ca analysis was 62 years compared to
45 years for patients with no P-Ca analyses. At the differ-
ent HCCs the number of standardised group analyses
including P-Ca analyses varied from zero to seven. The
locums were most numerous shown in Table 2, but had
short periods of attendance.Dalemo et al. BMC Family Practice 2010, 11:43
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The multilevel model
There was a substantial variation in number of P-Ca anal-
yses between HCCs and physicians. The four models
used in the analyses are shown in Table 3. In model A the
MORphysician+HCC indicated that for a patient changing
both GP and HCC, to a GP and HCC with higher odds for
a P-Ca analysis, the odds would in median increase by
2.31. The physician level, MORphysician = 1. 95 (95% CI: 1.
85-2.08) contributed more than the HCC level, MORHCC
= 1.65 (95% CI: 1.44-2.07). Figure 2 shows the residuals
for physicians (Panel A) and for HCCs (Panel B) from the
multilevel analysis.
Model B, C and D
Model B illustrates that female sex and increased number
of diagnoses in the risk score was associated with higher
propensity of a P-Ca analysis However, the inclusion of
other patient characteristics did not explain the variance
at the physician or HCC level. Model C illustrates that
house officers, preregistration house officer and younger
GPs ordered more P-Ca analysis compared to older GPs.
Table 1: Examples of diagnoses with strong influence of the chance of having a plasma calcium analyses the risk score 
equation. Total number of patients 154 629.
Title All the positive diagnoses in the stepwise 
regression
ICD-10 Codes Odds ratio 95%  CI Number of P-Ca
analysis
Neoplasms Sarcoidosis D86 8.4 3.3 21.4 21
Endocrine disorders Nontoxic goitre E04 3.1 2.2 4.5 177
Other disorders of thyroid E07 3.6 2.0 6.4 63
Mental disorders Unspecified dementia F03 2.5 2.0 3.0 523
Depressive episode F32 2.3 2.0 2.5 3196
Anxiety disorder F41.9 1.7 1.5 2.0 1438
Nonorganic sleeping disorders F51 1.5 1.3 1.7 1636
Diseases of the circulatory system Essential hypertension I10 1.8 1.7 1.9 12867
Atrial fibrillation and flutter I48 1.5 1.3 1.6 1792
Heart failure I50 1.7 1.5 1.9 1937
Diseases of the digestive system Constipation K59.0 1.7 1.4 2.0 730
Diseases of the musculoskeletal 
system
Other artritis and rheumatism unspecified M13 2.4 1.9 2.9 577
Myalgia M79.1 1.8 1.6 2.0 3749
Symptoms Abnormal blood-pressure reading, 
without diagnosis
R03.0 2.7 2.3 3.3 580
Polyuria R35 2.0 1.5 2.7 355
Headache R51 2.5 2.2 2.9 1392
Malaise and fatigue R53 6.5 5.9 7.2 2261
Contact with health services General medical examination Z00.0 3.3 3.0 3.7 1911
Worried well Z71.1 2.5 2.2 2.8 1732
Drug Calcium and vitamin D supplements 3.3 2.1 5.1 2938
Thiazide diuretics 1.3 1.2 1.4 8305
P-Ca = plasma calcium
95% CI = 95% credible intervalDalemo et al. BMC Family Practice 2010, 11:43
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Locums, regardless of age, ordered fewer P-Ca analyses.
There were no differences between male and female phy-
sicians. Inclusion of the physician characteristics did not
explain the variance in model A. Model D illustrates that
a high number of standardised group analyses were asso-
ciated with a high number of P-Ca analyses. The inclu-
sion of HCC characteristics did not explain the variance
at the higher levels.
Including all explanatory variables and controlling for
confounders, a patient changing both GP and HCC, from
low to high odds for P-Ca analysis, the odds for a P-Ca
analysis would in median increase by 2.5 times, MORphysi-
cian+HCC 2.45.
Discussion
The main finding of this study was that the ordering of P-
Ca analyses was influenced by factors both at the physi-
cian and at the HCC level, with the physician level being
more important than the HCC level. Theoretically, if a
patient were able to change both GP and HCC, the odds
of undergoing a P-Ca analysis would in median increase
Figure 1 Multilevel model employed in plasma calcium analyses in primary care County of Skaraborg, Sweden. A three-level logistic regres-
sion model including health care centre (HCC), physician and patient levels. At each level the analysed effect and the number of elements are de-
scribed. The arrows depict the nesting of patients within physicians and physicians within HCCs and crossing arrows the multiple memberships.
HCC
GP
Patient Patient Patient Patient
GP
Number Analyzed effects
HCC=Health Care Centre
Model
B
C
D 24
457
154 629
Group analyses
Sex
Title
Sex
P-Ca 2004*
Risk score
HCC
GP
Patient
*P-Ca= plasma calcium
Table 2: Staffing of physicians at health care centres, characteristics of physicians and number of patients visits and 
frequency of plasma calcium analyses per title in the county of Skaraborg during 2005.
Physicians Physicians/HCC Patients visits
Total
number
% 
women
Mean age 
(year)
SD Median 
age (year)
Range 
age (year)
Mean SD Median Range Total
number
With P-Ca 
test %
Preregistrati
on house 
officer
51 39 31 5.6 29 26-48 2.2 2.7 1 0-7 21 424 11
House 
officer
68 69 35 6.0 34 26-50 3.0 1.9 3 0-9 35 712 11
GP < 46 year 39 41 38 3.6 35 32-45 1.7 1.4 2 0-4 45 491 10
GP ≥ 46 year 85 32 55 8.6 52 46-67 3.7 1.6 4 1-6 92 109 8
Locum < 46 
year
112 17 36 5.4 36 27-45 6.2 8.9 3 0-36 23 153 7
Locum ≥ 46 
year
102 17 55 11.5 46 46-76 6.5 9.2 2 0-32 23 573 8
Total 457 32 43 11.6 41 26-76 23.3 18.1 18 2-85 241 529 9
GP = general practioner
HCC = health care centre
P-Ca = plasma calciumDalemo et al. BMC Family Practice 2010, 11:43
http://www.biomedcentral.com/1471-2296/11/43
Page 5 of 8
Table 3: Multi-level logistic regression analysis of plasma calcium analyses in primary care in the county of Skaraborg, 
Sweden
Model A Model B Model C Model D
Fixed effects OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)
Patient
Female - REF REF REF
Male - 0,80 (0,77-0,83) 0,80 (0,77-0,83) 0,80 (0,77-0,83)
P-Ca test 2004 - 1,44 (1,37-1,51) 1,44 (1,36-1,51) 1,44 (1,37-1,51)
Risc score
Group 1 - REF REF REF
Group 2 - 2,40 (2,15-2,70) 2,43 (2,18-2,71) 2,40 (2,14-2,68)
Group 3 - 4,51 (4,08-5,04) 4,56 (4,13-5,06) 4,51 (4,08-4,97)
Group 4 - 8,92 (8,11-9,87) 9,01 (8,14-9,96) 8,91 (8,12-9,78)
Group 5 - 25,8 (23,5-28,5) 26,1 (23,7-28,8) 25,8 (23,5-28,4)
Doctor
Female - - REF REF
Male - - 0,93 (0,78-1,09) 0,95 (0,78-1,24)
Preregistration house officer - - 1,48 (1,00-2,00) 1,51 (1,07-2,05)
House officer - - 1,69 (1,35-2,24) 1,57 (1,26-2,09)
GP < 46 year - - 1,30 (1,02-1,76) 1,16 (0,93-1,60)
GP ≥ 46 year - - REF REF
Locum < 46 year - - 0,84 (0,61-1,08) 0,78 (0,58-1,03)
Locum ≥ 46 year 0,73(0,57-0,94) 0,69(0,51-0,89)
HCC
Number groups include P-Ca
Group 1 - - - REF
Group 2 - - - 2,59 (1,56-3,53)
Group 3 - - - 2,79 (1,25-5,09)
Random effects Variance (95%CI) Variance (95%CI) Variance (95%CI) Variance (95%CI)
HCC (Intercept) 0,28 (0,15-0,58) 0,32 (0,16-0,67) 0,32 (0,18-0,66) 0,36 (0,16-0,80)
MORHCC 1,65 (1,44-2,07) 1,71 (1,47-2,18) 1,72 (1,49-2,17) 1,77 (1,48-2,34)
Physician (Intercept) 0,49 (0,41-0,59) 0,59 (0,50-0,71) 0,52 (0,43-0,62) 0,52 (0,43-0,63)
MORPhysician 1,95 (1,85-2,08) 2,09 (1,96-2,24) 1,98 (1,87-2,12) 1,99 (1,88-2,13)
HCC and Physician (Intercept) 0,77 0,91 0,84 0,88
MORHCC+Physician 2,31 2,48 2,4 2,45
DIC 89 550 76 438 76 427 76 427
Figure in italics are significant at 0.05 level
P-Ca = plasma calcium
95% CI = 95% credible interval
MOR = median odds ratio. OR = odds ratioDalemo et al. BMC Family Practice 2010, 11:43
http://www.biomedcentral.com/1471-2296/11/43
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by 2.45 times. Including compositional and contextual
characteristics in the model did not explain the variance
at the higher levels.
Overall 5,8% of the inhabitants underwent a P-Ca anal-
ysis, which is comparable with an earlier study from
Skaraborg (6,1%) [6] and two-fold compared with a study
from primary care in southern Stockholm [19] Female
patients and patients with previous P-Ca analysis were
more likely to have a P-Ca analysis, which could be
explained by women's greater risk of pHPT and recurrent
check-ups of patients with chronic diseases.
In order to control for compositional confounding at
the patient level we included an individual risk score for
P-Ca-analysis. The inclusion of this variable did not
explain the variation between physicians and between
HCCs. Further, our empirical analysis found that the sex
of the physician had no influence on P-Ca test ordering,
in contrast to a study from Israel where female physicians
ordered more test [20]. Older and more experienced phy-
sicians were less likely to order a P-Ca-test, which is in
line with previous studies indicating that test ordering
behaviour of GPs was influenced by years of experience
[21]. P-Ca analyses done as part of group analyses used in
surveillance of different chronic conditions may inflate
the number of P-Ca analyses [22]. However, even though
the number of group analyses was associated with higher
frequency of P-Ca analysis, it could not explain the varia-
tion at the HCC level.
As explained in previous studies [23]; the measures of
variation (e.g. median odds ratio) should be interpreted
only for the specific time and place of the study, as there
may be pattern of variance produced by different condi-
tions. The associations, however, between characteristics
of, on the one hand, the patients, physicians, and HCCs
and on the other the frequency of P-Ca analysis, intend to
provide information that can be generalised and applied
to contexts beyond the one where the study was per-
formed.
The risk for selection bias is low since this study is
based on a large sample from a primary care area serving
97% of the population. Moreover, as this study is a retro-
spective database study , the ordering of analyses is not
influenced by the study. A limitation of the study is that
the frequency of ICD coded patient visits varies both
between HCCs and according to diagnosis [9]. This might
affect the risk score calculation.
Different views of the reason for screening could also
affect the result. However national recommendations are
well known in Swedish primary care [1,2] thus the risk for
bias is minor. Due to regional variation in laboratory test-
ing [8] the results from this study might not be applicable
in all regions in Sweden.
Figure 2 Plasma calcium analyses per physician and HCC in primary care in county of Skaraborg, Sweden. A. percent plasma calcium analyses 
per physician. B. percent plasma calcium analyses per health care centre (HCC)
A
BDalemo et al. BMC Family Practice 2010, 11:43
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In this study only the variables available in the SPCD
database were included. In previous studies, other char-
acteristics of the physician, such as attitude to risk taking
and involvement in development of guidelines, explained
parts of the higher level variance [8].
We found that there was variation between physicians
and between HCC in ordering of P-Ca analysis, which is
in line with previous studies [24]. However, in this study
we also tried to quantify the contribution of each level by
using the median odds ratio. Even though our multilevel
approach identified factors, both at the physician and
HCC level, which are important to consider for under-
standing the inclination to order a P-Ca test, none of the
included variables could explain the variation at the
higher level. The identification of yet unidentified factors
that contribute to the variation is needed for monitoring
of practice variation and quality assessment and for
applying appropriate interventions to achieve optimal
frequency of P-Ca analyses.
Conclusions
National recommendations in Sweden have been issued
to increase the frequency of P-Ca analyses to detect more
patients with pHPT. There is a substantial variation in
number of P-Ca analyses primarily between physicians
but also between Health Care Centres. Female sex of the
patient and increasing number of diagnoses is associated
with higher propensity of P-Ca analysis. Physicians under
education order most P-Ca analyses and locum least, but
sex of the physician has no influence.
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